A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial: Midodrine and refractory gastroesophageal disease. Acta Biomedica Atenei Parmensis, Fidenza, Italy, v. 91, n. 1, p. 70–78, 2020. DOI: 10.23750/abm.v91i1.8486. Disponível em: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/8486.. Acesso em: 20 jun. 2024.